ScreenerHero vs Koyfin
Koyfin is a research terminal
with a screener attached.
ScreenerHero is a screener
with charts attached. $10 less.
Koyfin Plus is a well-regarded platform at $39/month — professional dashboards, macro data, and global charting. The screener is capable but secondary to the research workflow Koyfin is built around. ScreenerHero inverts the hierarchy: the screener is the product. If you spend most of your time filtering stocks rather than building dashboards, ScreenerHero is €29/month and covers the European microcap universe Koyfin misses.
Updated May 2026 · Honest comparison, including where Koyfin is genuinely better
The core difference
Koyfin: a professional research terminal
Koyfin is built for investors who want a Bloomberg-lite experience — custom dashboards, multi-asset charts, macro data, portfolio tracking, and peer comparisons. The screener is solid and covers global markets, but it is one feature among many. The $39/month Plus plan includes a lot of capability that screener-focused investors may never touch.
ScreenerHero: a screener, nothing else
ScreenerHero is built around one workflow: filter thousands of stocks by fundamental criteria and surface actionable ideas. The charts are functional but basic. There are no macro dashboards, no portfolio analytics, no economic indicator overlays. Every product decision prioritises screening speed and European fundamental coverage over research features. At €29/month, you are paying for exactly what you use.
Where Koyfin is genuinely better
Where ScreenerHero is genuinely better
Side-by-side comparison
| ScreenerHero | Koyfin Plus | |
|---|---|---|
| Primary use case | Screening-first — filter, rank, and surface ideas systematically | Dashboard and charting-first — monitor, analyse, and research |
| European stock coverage | All major European exchanges including microcaps on alternative markets | Global coverage — European large and mid caps well covered, microcap gaps |
| European microcap fundamentals | Reliable P/E, ROE, EV/EBITDA for EU small caps including alternative markets | Inconsistent below ~€300M — alternative market coverage limited |
| US stock coverage | Full — NYSE, NASDAQ, NYSE American | Comprehensive — major US exchanges and OTC |
| Canadian stock coverage | TSX and TSXV | Partial — major TSX names, limited TSXV coverage |
| Charting and dashboards | Basic price charts — functional, not the focus | Professional-grade — multi-asset charts, custom dashboards, macro overlays |
| Macro and economic data | Not available | GDP, inflation, yield curves, central bank rates — well integrated |
| Screener depth | Fundamental-first — P/E, P/B, ROE, EV/EBITDA, margins, dividend yield, beta | Screener available but secondary to the dashboard/research workflow |
| Watchlist and portfolio tracking | Basic watchlists in Pro | Advanced — multi-portfolio tracking, custom metrics, peer comparison |
| Free tier | Full screener free — no account required | Limited free tier — 2 saved screens, 2Y historical data, Koyfin branding |
| Price (paid plan) | €29/mo Pro | $39/mo Plus · $79/mo Pro — significantly more expensive |
| No account required | Yes — full screener works without login | No — account required for any feature access |
✓ = strong advantage · − = partial or qualified · ✗ = absent or weak
Which to use — by workflow
Can you use both?
Yes — they serve different parts of the research workflow. Use ScreenerHero to filter and surface stock ideas from the full US, Canadian, and European universe. Then open Koyfin to build a dashboard, chart the business over time, and compare it against peers. The tools are complementary rather than competing for the same workflow step. ScreenerHero is free to start — no account needed.
If screening is your primary workflow, stop paying for dashboard features you don't use.
P/E, ROE, EV/EBITDA, margins, dividend yield — US, Canadian, and European stocks including microcaps. Dense. Fast. Free to start, no account needed. Pro at €29/month.